{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:28:16Z","timestamp":1787113696279,"version":"build-2736575974"},"reference-count":130,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BrAshA-T, Action for A-T","award":["22QIMR01"],"award-info":[{"award-number":["22QIMR01"]}]},{"name":"Bellberry Ltd-Viertel Foundation Senior Medical Research Fellowship","award":["ViertelSMRF23013"],"award-info":[{"award-number":["ViertelSMRF23013"]}]},{"name":"Medical Research Future Fund Australia","award":["GA89314"],"award-info":[{"award-number":["GA89314"]}]},{"award":["GA89314"],"award-info":[{"award-number":["GA89314"]}],"id":[{"id":"https:\/\/ror.org\/0513v5k17","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008613","name":"Wesley Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008613","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/00pvy2x95","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>At present, there is no cure for the human genetic disorder ataxia-telangiectasia (A-T), which is managed by supportive care. This disorder arises due to mutations in the ATM (ataxia-telangiectasia mutated) gene and is characterised by a defect in the response to DNA damage, oxidative stress, mitochondrial dysfunction and immune deficiency. The ATM protein is activated by DNA damage, reactive oxygen species (ROS), and a variety of other stimuli, which leads to the phosphorylation or altered cellular localisation of multiple protein substrates that participate in cellular defence pathways. ATM plays a central role in orchestrating cellular defence against stress, which forms a focal point for approaches to treating the symptoms in this disorder. These strategies involve boosting mitochondrial function and dampening the inflammatory response. A more direct approach to treatment is gene therapy, yet the leading method using Adeno-Associated Virus (AAV) is hampered by the large size of the ATM gene itself. The use of antisense oligonucleotides (ASO) as an alternative gene therapeutic approach to treat patients has been increasingly utilised. However, only certain mutations fit the criteria for ASO-based intervention, which encourages rescue through readthrough of premature truncation mutations. For this reason, small-molecule-based therapies addressing the multi-system nature of the disease are urgently required. We address these different approaches to therapy and the outcome of numerous recent clinical trials with A-T patients, as well as ongoing research that has potential to lead to therapy.<\/jats:p>","DOI":"10.3390\/ijms27167347","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:42:17Z","timestamp":1786974137000},"page":"7347","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent Advances in Therapy for the Neurodegenerative Disorder Ataxia-Telangiectasia"],"prefix":"10.3390","volume":"27","author":[{"given":"Sam","family":"Nayler","sequence":"first","affiliation":[{"name":"QIMR Berghofer Research Institute, Brisbane, QLD 4006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3034-1351","authenticated-orcid":false,"given":"Simon","family":"Foster","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Research Institute, Brisbane, QLD 4006, Australia"},{"name":"Department of Pharmacology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia"},{"name":"School of Biomedical Sciences, University of Queensland, St Lucia, QLD 4072, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lavin","sequence":"additional","affiliation":[{"name":"Frazer Institute, University of Queensland, Royal Brisbane and Women\u2019s Hospital, Herston, QLD 4029, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-6471","authenticated-orcid":false,"given":"David","family":"Coman","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Wesley Medical Research, Auchenflower, Brisbane, QLD 4066, Australia"},{"name":"Department of Metabolic Medicine, Queensland Children\u2019s Hospital, South Brisbane, QLD 4101, Australia"},{"name":"Child Health Research Centre, Faculty of Medicine, University of Queensland, South Brisbane, QLD 4101, Australia"},{"name":"School of Medicine, Griffith University, Gold Coast, QLD 4222, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.7792600","article-title":"A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase","volume":"268","author":"Savitsky","year":"1995","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrm2514","article-title":"Ataxia-telangiectasia: From a rare disorder to a paradigm for cell signalling and cancer","volume":"9","author":"Lavin","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathol-011811-132509","article-title":"ATM and the Molecular Pathogenesis of Ataxia Telangiectasia","volume":"7","author":"McKinnon","year":"2012","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_4","unstructured":"Adam, M.P., Bick, S., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1999). Ataxia-Telangiectasia. GeneReviews\u00ae, University of Washington."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrm3546","article-title":"The ATM protein kinase: Regulating the cellular response to genotoxic stress, and more","volume":"14","author":"Shiloh","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","article-title":"DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation","volume":"421","author":"Bakkenist","year":"2003","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1093\/emboj\/cdg541","article-title":"Requirement of the MRN complex for ATM activation by DNA damage","volume":"22","author":"Uziel","year":"2003","journal-title":"EMBO J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"103647","DOI":"10.1016\/j.dnarep.2024.103647","article-title":"A-T neurodegeneration and DNA damage-induced transcriptional stress","volume":"135","author":"Paull","year":"2024","journal-title":"DNA Repair"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1126\/science.1192912","article-title":"ATM activation by oxidative stress","volume":"330","author":"Guo","year":"2010","journal-title":"Science"},{"key":"ref_10","first-page":"200","article-title":"Mitochondrial metabolism of reactive oxygen species","volume":"70","author":"Andreyev","year":"2005","journal-title":"Biochemistry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"eadi8291","DOI":"10.1126\/sciadv.adi8291","article-title":"Structural insights into the activation of ataxia-telangiectasia mutated by oxidative stress","volume":"9","author":"Howes","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101972","DOI":"10.1016\/j.isci.2020.101972","article-title":"Impaired endoplasmic reticulum-mitochondrial signaling in ataxia-telangiectasia","volume":"24","author":"Yeo","year":"2021","journal-title":"iScience"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"113555","DOI":"10.1016\/j.celrep.2023.113555","article-title":"Cell stretching activates an ATM mechano-transduction pathway that remodels cytoskeleton and chromatin","volume":"42","author":"Bastianello","year":"2023","journal-title":"Cell Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/adc.2006.094268","article-title":"Survival probability in ataxia telangiectasia","volume":"91","author":"Crawford","year":"2005","journal-title":"Arch. Dis. Child."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpeds.2003.12.046","article-title":"Immunodeficiency and infections in ataxia-telangiectasia","volume":"144","author":"Crawford","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jaci.2013.01.053","article-title":"Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity","volume":"131","author":"Driessen","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0002-9394(02)01796-8","article-title":"Ocular manifestations of ataxia-telangiectasia","volume":"134","author":"Farr","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-3476(00)70106-5","article-title":"Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia","volume":"136","author":"Crawford","year":"2000","journal-title":"J. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/MPG.0000000000001036","article-title":"Liver Disease in Pediatric Patients With Ataxia Telangiectasia: A Novel Report","volume":"62","author":"Weiss","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Donath, H., Woelke, S., Theis, M., He\u00df, U., Knop, V., Herrmann, E., Krauskopf, D., Kieslich, M., Schubert, R., and Zielen, S. (2019). Progressive Liver Disease in Patients With Ataxia Telangiectasia. Front. Pediatr., 7.","DOI":"10.3389\/fped.2019.00458"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: A review","volume":"11","author":"Wright","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Woelke, S., Valesky, E., Bakhtiar, S., Pommerening, H., Pfeffermann, L.M., Schubert, R., and Zielen, S. (2018). Treatment of Granulomas in Patients With Ataxia Telangiectasia. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02000"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"102355","DOI":"10.1016\/j.xcrm.2025.102355","article-title":"ATM deficiency drives phenotypic diversity and Purkinje cell degeneration in a macaque model of ataxia-telangiectasia","volume":"6","author":"Xu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100200","DOI":"10.1016\/j.slasd.2024.100200","article-title":"Drug repurposing screen for the rare disease ataxia-telangiectasia","volume":"30","author":"Jayanth","year":"2024","journal-title":"SLAS Discov. Adv. Sci. Drug Discov."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40259-024-00644-7","article-title":"Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases","volume":"38","author":"Chen","year":"2024","journal-title":"BioDrugs"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41586-023-06277-0","article-title":"A framework for individualized splice-switching oligonucleotide therapy","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wilton-Clark, H., Yan, E., and Yokota, T. (2024). Preparing for Patient-Customized N-of-1 Antisense Oligonucleotide Therapy to Treat Rare Diseases. Genes, 15.","DOI":"10.20944\/preprints202405.1955.v1"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/jcbfm.2012.35","article-title":"Updated Energy Budgets for Neural Computation in the Neocortex and Cerebellum","volume":"32","author":"Howarth","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1083\/jcb.201806197","article-title":"ATM is activated by ATP depletion and modulates mitochondrial function through NRF1","volume":"218","author":"Chow","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e70304","DOI":"10.1111\/jnc.70304","article-title":"Metabolic Flexibility of Microglia: Energy Substrate Utilization and Impact on Neuronal Metabolism","volume":"169","author":"Westi","year":"2025","journal-title":"J. Neurochem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/emboj.2010.330","article-title":"ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair","volume":"30","author":"Cosentino","year":"2010","journal-title":"EMBO J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1074\/jbc.M106798200","article-title":"Accumulation of DNA Damage and Reduced Levels of Nicotine Adenine Dinucleotide in the Brains of Atm-deficient Mice","volume":"277","author":"Stern","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/hmg\/ddm166","article-title":"Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells","volume":"16","author":"Ambrose","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1172\/JCI31604","article-title":"Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis","volume":"117","author":"Eaton","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.freeradbiomed.2011.11.026","article-title":"The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+\/\u2013\/ApoE\u2013\/\u2013 mice","volume":"52","author":"Mercer","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/mt.2012.203","article-title":"Reducing Mitochondrial ROS Improves Disease-related Pathology in a Mouse Model of Ataxia-telangiectasia","volume":"21","author":"Krause","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.dnarep.2013.11.002","article-title":"Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia","volume":"13","author":"Sharma","year":"2014","journal-title":"DNA Repair"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-41108-1","article-title":"Ataxia-Telangiectasia Mutated is located in cardiac mitochondria and impacts oxidative phosphorylation","volume":"9","author":"Blignaut","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bbrc.2013.12.139","article-title":"Mitochondria are required for ATM activation by extranuclear oxidative stress in cultured human hepatoblastoma cell line Hep G2 cells","volume":"443","author":"Morita","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_40","first-page":"1849","article-title":"Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice","volume":"61","author":"Kamsler","year":"2001","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11453","DOI":"10.1523\/JNEUROSCI.23-36-11453.2003","article-title":"Oxidative Stress Is Responsible for Deficient Survival and Dendritogenesis in Purkinje Neurons from Ataxia-Telangiectasia Mutated Mutant Mice","volume":"23","author":"Chen","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1158\/0008-5472.CAN-04-0442","article-title":"Effect of N-Acetyl Cysteine on Oxidative DNA Damage and the Frequency of DNA Deletions in Atm-Deficient Mice","volume":"64","author":"Reliene","year":"2004","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cmet.2016.09.004","article-title":"NAD + Replenishment Improves Lifespan and Healthspan in Ataxia Telangiectasia Models via Mitophagy and DNA Repair","volume":"24","author":"Fang","year":"2016","journal-title":"Cell Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e13329","DOI":"10.1111\/acel.13329","article-title":"NAD+ supplementation prevents STING-induced senescence in ataxia telangiectasia by improving mitophagy","volume":"20","author":"Yang","year":"2021","journal-title":"Aging Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41514-021-00078-3","article-title":"NAD+ augmentation with nicotinamide riboside improves lymphoid potential of Atm\u2212\/\u2212 and old mice HSCs","volume":"7","author":"Zong","year":"2021","journal-title":"npj Aging Mech. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e2419196122","DOI":"10.1073\/pnas.2419196122","article-title":"The cGAS\u2013STING, p38 MAPK, and p53 pathways link genome instability to accelerated cellular senescence in ATM-deficient murine lung fibroblasts","volume":"122","author":"Haj","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s44324-025-00067-0","article-title":"The role of NAD+ metabolism and its modulation of mitochondria in aging and disease","volume":"3","author":"Yusri","year":"2025","journal-title":"npj Metab. Health Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/mds.28788","article-title":"Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia","volume":"36","author":"Veenhuis","year":"2021","journal-title":"Mov. Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/mds.29645","article-title":"Long-Term Nicotinamide Riboside Use Improves Coordination and Eye Movements in Ataxia Telangiectasia","volume":"39","author":"Presterud","year":"2023","journal-title":"Mov. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12311-021-01257-4","article-title":"Neurofilament Light Chain is a Biomarker of Neurodegeneration in Ataxia Telangiectasia","volume":"21","author":"Donath","year":"2022","journal-title":"Cerebellum"},{"key":"ref_51","first-page":"078","article-title":"Nicotinamide Riboside for Ataxia Telangiectasia: A Report of an Early Treated Individual","volume":"54","author":"Steinbruecker","year":"2022","journal-title":"Neuropediatrics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.37765\/ajmc.2020.88480","article-title":"Long-chain fatty acid oxidation disorders and current management strategies","volume":"26","author":"Vockley","year":"2020","journal-title":"Am. J. Manag. Care"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"598760","DOI":"10.3389\/fgene.2020.598760","article-title":"Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders","volume":"11","author":"Sklirou","year":"2021","journal-title":"Front. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/jimd.12640","article-title":"Triheptanoin for the treatment of long-chain fatty acid oxidation disorders: Final results of an open-label, long-term extension study","volume":"46","author":"Vockley","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"101354","DOI":"10.1016\/j.molmet.2021.101354","article-title":"An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)","volume":"54","author":"Yeo","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"105840","DOI":"10.1016\/j.ebiom.2025.105840","article-title":"Phase 2a\/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: Treating mitochondrial dysfunction with anaplerosis","volume":"118","author":"Lynch","year":"2025","journal-title":"EBioMedicine"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Kaya, E., Smith, D.A., Smith, C., Boland, B., Strupp, M., and Platt, F.M. (2020). Beneficial Effects of Acetyl-DL-Leucine (ADLL) in a Mouse Model of Sandhoff Disease. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041050"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.0953-816x.2000.01447.x","article-title":"In vitro effects of acetyl-dl-leucine (tanganil\u00ae) on central vestibular neurons and vestibulo-ocular networks of the guinea-pig","volume":"13","author":"Vibert","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-88693-8","article-title":"N-Acetyl-l-leucine improves functional recovery and attenuates cortical cell death and neuroinflammation after traumatic brain injury in mice","volume":"11","author":"Hegdekar","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4103\/1673-5374.382247","article-title":"Autophagy in neuroinflammation after traumatic brain injury","volume":"19","author":"Sarkar","year":"2023","journal-title":"Neural Regen. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"fcaa148","DOI":"10.1093\/braincomms\/fcaa148","article-title":"Acetyl-leucine slows disease progression in lysosomal storage disorders","volume":"3","author":"Kaya","year":"2020","journal-title":"Brain Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-95255-5","article-title":"Acetylation turns leucine into a drug by membrane transporter switching","volume":"11","author":"Churchill","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/08830738211028394","article-title":"Effects of Acetyl-DL-Leucine on Ataxia and Downbeat-Nystagmus in Six Patients With Ataxia Telangiectasia","volume":"37","author":"Brueggemann","year":"2021","journal-title":"J. Child Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s12311-022-01504-2","article-title":"The Effects of N-Acetyl-L-Leucine on the Improvement of Symptoms in a Patient with Multiple Sulfatase Deficiency","volume":"22","author":"Houra","year":"2022","journal-title":"Cerebellum"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejpn.2024.04.009","article-title":"Efficacy and safety of N-acetyl-L-leucine in patients with ataxia telangiectasia: A randomized, double-blind, placebo-controlled, crossover clinical trial","volume":"50","author":"Sahebkar","year":"2024","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4161\/15384101.2014.988020","article-title":"Somatic inactivation of ATM in hematopoietic cells predisposes mice to cyclin D3 dependent T cell acute lymphoblastic leukemia","volume":"14","author":"Ehrlich","year":"2015","journal-title":"Cell Cycle"},{"key":"ref_67","first-page":"1637","article-title":"Multidisciplinary Management of Ataxia Telangiectasia: Current Perspectives","volume":"ume 14","author":"Wright","year":"2021","journal-title":"J. Multidiscip. Heal."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"113622","DOI":"10.1016\/j.celrep.2023.113622","article-title":"ATM-deficiency-induced microglial activation promotes neurodegeneration in ataxia-telangiectasia","volume":"43","author":"Lai","year":"2023","journal-title":"Cell Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jpeds.2009.12.007","article-title":"Elevated Serum IL-8 Levels in Ataxia Telangiectasia","volume":"156","author":"Collaco","year":"2010","journal-title":"J. Pediatr."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jpeds.2016.01.002","article-title":"Serum Interleukin-6 Levels and Pulmonary Function in Ataxia-Telangiectasia","volume":"171","author":"Collaco","year":"2016","journal-title":"J. Pediatr."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Biagiotti, S., Bianchi, M., Rossi, L., Chessa, L., and Magnani, M. (2019). Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0216668"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1111\/febs.13901","article-title":"Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response","volume":"283","author":"Biagiotti","year":"2016","journal-title":"FEBS J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"41352","DOI":"10.1074\/jbc.M112.344473","article-title":"Dexamethasone Partially Rescues Ataxia Telangiectasia-mutated (ATM) Deficiency in Ataxia Telangiectasia by Promoting a Shortened Protein Variant Retaining Kinase Activity","volume":"287","author":"Menotta","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11010-014-2013-7","article-title":"Forward subtractive libraries containing genes transactivated by dexamethasone in ataxia-telangiectasia lymphoblastoid cells","volume":"392","author":"Biagiotti","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/ene.12024","article-title":"Betamethasone therapy in ataxia telangiectasia: Unraveling the rationale of this serendipitous observation on the basis of the pathogenesis","volume":"20","author":"Giardino","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/mds.25126","article-title":"A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia","volume":"27","author":"Zannolli","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-9-5","article-title":"Intra-Erythrocyte Infusion of Dexamethasone Reduces Neurological Symptoms in Ataxia Teleangiectasia Patients: Results of a Phase 2 Trial","volume":"9","author":"Chessa","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1212\/NXI.0000000000000098","article-title":"Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia","volume":"2","author":"Leuzzi","year":"2015","journal-title":"Neurol.-Neuroimmunol. Neuroinflamm."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/psp4.70103","article-title":"Population Pharmacokinetic Modeling and Pediatric Exposure of Dexamethasone Sodium Phosphate Encapsulated in Erythrocytes (eDSP) Administered Monthly for Treatment of Neurological Symptoms of Patients With Ataxia Telangiectasia","volume":"14","author":"Ozdin","year":"2025","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"103907","DOI":"10.1016\/j.dnarep.2025.103907","article-title":"Lets talk about ataxia-telangiectasia: Meeting report of the AT clinical research conference June 2025","volume":"155","author":"Coman","year":"2025","journal-title":"DNA Repair"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/cge.12453","article-title":"Ataxia telangiectasia: More variation at clinical and cellular levels","volume":"87","author":"Taylor","year":"2014","journal-title":"Clin. Genet."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1073\/pnas.94.15.8021","article-title":"Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/hmg\/ddaa023","article-title":"Correction of ATM mutations in iPS cells from two ataxia-telangiectasia patients restores DNA damage and oxidative stress responses","volume":"29","author":"Withey","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41467-018-07729-2","article-title":"ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks","volume":"10","author":"Balmus","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"13182","DOI":"10.1073\/pnas.0504211102","article-title":"A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM","volume":"102","author":"Sun","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1093\/nar\/gkz110","article-title":"MRE11 UFMylation promotes ATM activation","volume":"47","author":"Wang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-09175-0","article-title":"UFL1 promotes histone H4 ufmylation and ATM activation","volume":"10","author":"Qin","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"eaax8214","DOI":"10.1126\/sciadv.aax8214","article-title":"STK38 promotes ATM activation by acting as a reader of histone H4 ufmylation","volume":"6","author":"Qin","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s42764-022-00076-z","article-title":"Dynamic recruitment of UFM1-specific peptidase 2 to the DNA double-strand breaks regulated by WIP1","volume":"3","author":"Qin","year":"2022","journal-title":"Genome Instab. Dis."},{"key":"ref_91","first-page":"1","article-title":"Alpha-ketoglutarate mitigates insulin resistance and metabolic inflexibility in a mouse model of Ataxia-Telangiectasia","volume":"16","author":"Sun","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-025-60304-4","article-title":"Loss of CD98HC phosphorylation by ATM impairs antiporter trafficking and drives glutamate toxicity in Ataxia telangiectasia","volume":"16","author":"Romero","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1002\/jnr.21444","article-title":"The glutamate-glutamine cycle is not stoichiometric: Fates of glutamate in brain","volume":"85","author":"McKenna","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"ref_94","first-page":"839","article-title":"A high frequency of distinct ATM gene mutations in ataxia-telangiectasia","volume":"59","author":"Wright","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jaci.2011.03.052","article-title":"Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype","volume":"128","author":"Micol","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"15676","DOI":"10.1073\/pnas.0405155101","article-title":"Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons","volume":"101","author":"Lai","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/mt.2013.150","article-title":"A New Series of Small Molecular Weight Compounds Induce Read Through of All Three Types of Nonsense Mutations in the ATM Gene","volume":"21","author":"Du","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e64695","DOI":"10.7554\/eLife.64695","article-title":"A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation","volume":"10","author":"Perez","year":"2021","journal-title":"eLife"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/sj.bjc.6605066","article-title":"Targeting HSP90 for cancer therapy","volume":"100","author":"Mahalingam","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/nep3.68","article-title":"Decoding the role of large heat shock proteins in the progression of neuroinflammation-mediated neurodegenerative disorders","volume":"3","author":"Saxena","year":"2025","journal-title":"Neuroprotection"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"103269","DOI":"10.1016\/j.redox.2024.103269","article-title":"Oxidative stress and the multifaceted roles of ATM in maintaining cellular redox homeostasis","volume":"75","author":"Lee","year":"2024","journal-title":"Redox Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"120110","DOI":"10.1016\/j.bbamcr.2026.120110","article-title":"ATM kinase phosphorylates HSP90 on T297 changing its conformation dynamics and promoting its interaction with HER2 receptor tyrosine kinase","volume":"1873","author":"Fianco","year":"2026","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e2518589122","DOI":"10.1073\/pnas.2518589122","article-title":"ATM interaction with GRP94 modulates oncogenic receptor expression and signaling and microglial activation","volume":"122","author":"Burrell","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_104","first-page":"109","article-title":"A rat model of ataxia-telangiectasia: Evidence for a neurodegenerative phenotype","volume":"26","author":"Quek","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/nar\/gkac104","article-title":"Persistent DNA damage associated with ATM kinase deficiency promotes microglial dysfunction","volume":"50","author":"Bourseguin","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/glia.24122","article-title":"Dysfunction of cerebellar microglia in Ataxia-telangiectasia","volume":"70","author":"Levi","year":"2021","journal-title":"Glia"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"17076","DOI":"10.1038\/cddiscovery.2017.76","article-title":"Glucose-regulated protein 75 determines ER\u2013mitochondrial coupling and sensitivity to oxidative stress in neuronal cells","volume":"3","author":"Honrath","year":"2017","journal-title":"Cell Death Discov."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"12688","DOI":"10.1073\/pnas.94.23.12688","article-title":"Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia\u2013telangiectasia","volume":"94","author":"Kuljis","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"12653","DOI":"10.1073\/pnas.95.21.12653","article-title":"Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice","volume":"95","author":"Eilam","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1073\/pnas.97.7.3336","article-title":"Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice","volume":"97","author":"Borghesani","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.freeradbiomed.2006.06.018","article-title":"Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant","volume":"41","author":"Gueven","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ajpath.2011.05.026","article-title":"A Role for Vascular Deficiency in Retinal Pathology in a Mouse Model of Ataxia-Telangiectasia","volume":"179","author":"Galron","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1440-1789.2011.01210.x","article-title":"Heterotopic Purkinje cells in ataxia-telangiectasia","volume":"32","author":"Bottini","year":"2011","journal-title":"Neuropathology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41467-025-66710-y","article-title":"Microgliopathy as a primary mediator of neuronal death in models of Friedreich\u2019s Ataxia","volume":"17","author":"Pernaci","year":"2026","journal-title":"Nat. Commun."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1534\/genetics.113.150854","article-title":"The Innate Immune Response Transcription Factor Relish Is Necessary for Neurodegeneration in a Drosophila Model of Ataxia-Telangiectasia","volume":"194","author":"Petersen","year":"2013","journal-title":"Genetics"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1093\/hmg\/ddv356","article-title":"A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease","volume":"24","author":"Beraldi","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"523","DOI":"10.5966\/sctm.2012-0024","article-title":"Induced Pluripotent Stem Cells from Ataxia-Telangiectasia Recapitulate the Cellular Phenotype","volume":"1","author":"Nayler","year":"2012","journal-title":"STEM CELLS Transl. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1038\/srep05421","article-title":"Ataxia telangiectasia derived iPS cells show preserved x-ray sensitivity and decreased chromosomal instability","volume":"4","author":"Fukawatase","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.scr.2016.08.006","article-title":"Robust reprogramming of Ataxia-Telangiectasia patient and carrier erythroid cells to induced pluripotent stem cells","volume":"17","author":"Bhatt","year":"2016","journal-title":"Stem Cell Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"102528","DOI":"10.1016\/j.scr.2021.102528","article-title":"Ataxia Telangiectasia iPSC line generated from a patient olfactory biopsy identifies novel disease-causing mutations","volume":"56","author":"Leeson","year":"2021","journal-title":"Stem Cell Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1H.5.1","DOI":"10.1002\/9780470151808.sc01h05s20","article-title":"Derivation of Cerebellar Neurons from Human Pluripotent Stem Cells","volume":"20","author":"Erceg","year":"2012","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.celrep.2014.12.051","article-title":"Self-Organization of Polarized Cerebellar Tissue in 3D Culture of Human Pluripotent Stem Cells","volume":"10","author":"Muguruma","year":"2015","journal-title":"Cell Rep."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-91846-4","article-title":"High-resolution transcriptional landscape of xeno-free human induced pluripotent stem cell-derived cerebellar organoids","volume":"11","author":"Nayler","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)","volume":"89","author":"Lynch","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14737175.2024.2310617","article-title":"Omaveloxolone for the treatment of Friedreich ataxia: Clinical trial results and practical considerations","volume":"24","author":"Lynch","year":"2024","journal-title":"Expert Rev. Neurother."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12311-023-01568-8","article-title":"A Milestone in the Treatment of Ataxias: Approval of Omaveloxolone for Friedreich Ataxia","volume":"23","author":"Subramony","year":"2023","journal-title":"Cerebellum"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1212\/WNL.0b013e3181d31e23","article-title":"Riluzole in cerebellar ataxia: A randomized, double-blind, placebo-controlled pilot trial","volume":"74","author":"Ristori","year":"2010","journal-title":"Neurology"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1474-4422(15)00201-X","article-title":"Riluzole in patients with hereditary cerebellar ataxia: A randomised, double-blind, placebo-controlled trial","volume":"14","author":"Romano","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/14737175.2022.2029703","article-title":"Current and emerging treatment modalities for spinocerebellar ataxias","volume":"22","author":"Ghanekar","year":"2022","journal-title":"Expert Rev. Neurother."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41593-025-02118-7","article-title":"Large-scale drug screening in iPSC-derived motor neurons from sporadic ALS patients identifies a potential combinatorial therapy","volume":"29","author":"Bye","year":"2025","journal-title":"Nat. Neurosci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7347\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:21:10Z","timestamp":1787113270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":130,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167347"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167347","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}